Enzyme-Linked Immunosorbent Assay (ELISA).: Market Research Report
Contents
I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
ELISA Kits
ELISA Development Sets and Antibody Pairs
II. A US MARKET REPORT
1.INDUSTRY OVERVIEW
ELISA – A Renowned and Proven Assay Format
Factors Sustaining Growth
Factors Restraining Growth
Current and Future Analysis
ELISA Amid A Challenging Environment
Strategies to Counter Competition
Commoditization: A Key Issue Facing ELISA Product Manufacturers
2.COMPETITIVE LANDSCAPE
ELISA Products of Select Manufacturers
Table 1: Leading Players in the US Research ELISA Market (2007): Percentage Share Breakdown of Revenues for R&D Systems, Invitrogen Corporation, Thermo Fisher Scientific Inc., BD Biosciences, and Others (includes corresponding Graph/Chart)
Table 2: Leading Players in the US Market for Research ELISA Kits (2007): Percentage Share Breakdown of Revenues for R&D Systems, Invitrogen Corporation, and Others (includes corresponding Graph/Chart)
Table 3: Leading Players in the US Market for Research ELISA Development Sets and Antibody Pairs (2007): Percentage Share Breakdown of Revenues for R&D Systems, Thermo Fisher Scientific Inc., BD Biosciences, Invitrogen Corporation, and Others (includes corresponding Graph/Chart)
3.IMMUNOCHEMISTRY – AN INTRODUCTION
Comparison of Various Immunoassay Technologies
4.PRODUCT OVERVIEW
Enzyme-Linked Immunosorbent Assay (ELISA) – An Introduction
ELISA Technique
Steps in ELISA Technique
Testing for Proteins
History
Types of ELISA
Indirect ELISA
Drawbacks
Sandwich ELISA
Advantages
Competitive ELISA
Reverse ELISA
Advantages
Research ELISA Market
ELISA Development Sets and Antibody Pairs
ELISA Kits
Applications of ELISA
ELISA in HIV
5.PRODUCT INNOVATIONS/INTRODUCTIONS
bioMérieux Obtains FDA Approval for VIDAS® FPSA Test
Millipore and CXR Launch ToxReporter™
Omega Unveils Pathozyme ElisaSure Kit
CISBIO Introduces ELISA Kit
Inverness Medical Rolls Out Clearview TB ELISA Test
Trevigen Introduces PD PAR ELISA Assay
Millipore Introduces OxyELISA™ Kit
PerkinElmer Introduces New AlphaLISA™ Immunoassay Kits
BioCurex to Commercially Launch Recaf ELISA Blood Tests
DiscoveRx Launches New PhosphoQuest™ ELISA Assays
6.RECENT INDUSTRY ACTIVITY
Invitrogen Merges with Applied Biosystems to Form Life Technologies
MBL Receives FDA Clearance for BP230 and BP180 ELISA Kits
Assay Designs and Abnova Sign a Strategic Agreement
SMAF and Assay Designs Sign Strategic Agreement
Thermo Fisher Takes Over Affinity BioReagents
FASgen Enters into Agreement with Tetracore
7.FOCUS ON SELECT PLAYERS
Abbott Diagnostics (US)
Becton, Dickinson and Company (US)
BioMérieux SA (France)
Biomerieux Inc (US)
Bio-Rad Laboratories, Inc. (US)
Life Technologies Corporation (US)
Millipore Corporation (US)
Ortho-Clinical Diagnostics, Inc. (US)
Research & Diagnostics Systems, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
8.US MARKET PERSPECTIVE
Table 4: US Recent Past, Current & Future Analysis for Research ELISA Market by Product Segment – ELISA Development Sets and Antibody Pairs, and ELISA Kits Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart)
Table 5: US Historic Review for Research ELISA Market by Product Segment – ELISA Development Sets and Antibody Pairs, and ELISA Kits Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart)
Table 6: US 13-Year Perspective for Research ELISA Market by Product Segment – Percentage Breakdown of Dollar Sales for ELISA Development Sets and Antibody Pairs, and ELISA Kits Markets for 2003, 2009 & 2015
III. COMPETITIVE LANDSCAPE
Total Companies Profiled: 100 (including Divisions/Subsidiaries - 106)
Region/CountryPlayers
The United States
Canada
Japan
Europe
France
Germany
The United Kingdom
Rest of Europe
Asia-Pacific (Excluding Japan)
Please read Global Industry Analysts, Inc., - Sales Policy below before placing an order:
All Publications from Global Industry Analysts, Inc., (GIA) are protected per protocols of the Universal Copyrights Convention and the United States Copyrights Office. It is GIA’s policy that once purchased, these publications may not be returned for any reason. GIA makes all reasonable attempts to report current and accurate information in its publications.
GIA will not be responsible for any type of damages (financial or other) incurred by the client (company or individual) in the usage of GIA’s publications or services. The client agrees that in case a legal resolution becomes necessary, the venue shall be the city of San Francisco, California, USA. Under any circumstances, GIA’s liability shall be limited to the exact price of the product or service paid to GIA by the client.
This publication is sold as a single-user single-site license. Electronic versions operate like normal PDF files once installed and permit unlimited print and cut & paste. Digital controls and watermarks are set on electronic copies and are protected against copying. Extra licenses can be purchased for the same location at 10% of the list price.